Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent.

[1]  P. Saulnier,et al.  Reorganization of lipid nanocapsules at air-water interface. I. Kinetics of surface film formation. , 2005, Colloids and surfaces. B, Biointerfaces.

[2]  J. Benoit,et al.  Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface , 2005, Electrophoresis.

[3]  G. Maulucci,et al.  Particle size distribution in DMPC vesicles solutions undergoing different sonication times. , 2005, Biophysical journal.

[4]  F. Boury,et al.  Formation and rheological properties of the supercritical CO2-water pure interface. , 2005, The journal of physical chemistry. B.

[5]  E. Roux,et al.  Novel Long-Circulating Lipid Nanocapsules , 2004, Pharmaceutical Research.

[6]  J. Behr,et al.  The cyclin-dependent kinase inhibitor p21cip1/waf1 enhances the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells , 2004 .

[7]  J. Benoit,et al.  Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. , 2004, International journal of pharmaceutics.

[8]  P. Renard,et al.  Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents. , 2004, Journal of medicinal chemistry.

[9]  J. Benoit,et al.  A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers , 2002, Pharmaceutical Research.

[10]  R. Ozols,et al.  Focus on epithelial ovarian cancer. , 2004, Cancer cell.

[11]  M. Markman,et al.  Primary ovarian cancer chemotherapy: current standards of care , 2003, British Journal of Cancer.

[12]  Shu Chien,et al.  Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases , 2003 .

[13]  J. Benoit,et al.  The influence of lipid nanocapsule composition on their size distribution. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  J. Benoit,et al.  Rheological study of lysozyme and PEG2000 at the air-water and dichloromethane-water interfaces under ramp type or sinusoidal perturbations , 2002 .

[15]  J. Benoit,et al.  New lipid nanocapsules exhibit sustained release properties for amiodarone. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[16]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[17]  J. Benoit,et al.  Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface. , 2002, International journal of pharmaceutics.

[18]  J. Benoit,et al.  Influence of some formulation parameters on lysozyme adsorption and on its stability in solution. , 2002, International journal of pharmaceutics.

[19]  J. Benoit,et al.  Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting. , 2002, International journal of pharmaceutics.

[20]  F. Boury,et al.  Rheological Model for the Study of Dilational Properties of Monolayers. Comportment of Dipalmitoylphosphatidylcholine (DPPC) at the Dichloromethane (DCM)/Water Interface under Ramp Type or Sinusoidal Perturbations , 2001 .

[21]  P. Renard,et al.  Design, synthesis and antiproliferative activity of tripentones: a new series of antitubulin agents. , 2001, Bioorganic & medicinal chemistry letters.

[22]  F. Boury,et al.  Effect of hydrophobic protein SP-C on structure and dilatational properties of the model monolayers of pulmonary surfactant , 1996 .

[23]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[24]  F. Boury,et al.  Dilatational Properties of Adsorbed Poly(D,L-lactide) and Bovine Serum Albumin Monolayers at the Dichloromethane/Water Interface , 1995 .

[25]  M. Poupon,et al.  Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363. , 1991, Cancer research.